DEPTULA-HICKS DARLENE M — SEC insider filings
SEC reporting owner CIK 1089409. 9 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-11-24 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 7,500 shares, $4,875 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 7,500 shares @ $0.65 ($4,875) in Aldeyra Therapeutics, Inc., filed 2026-11-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | Director | 2 | 1 leg · 7,500 sh · $4,875 | — | 2 |
| F-star Therapeutics, Inc. (FSTX) | See Remarks | 7 | — | — | 13 |
Insider filings — DEPTULA-HICKS DARLENE M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase (P): 7,500 @ $0.65 | EDGAR |
| 2026-06-11 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 84,557 (derivative) @ $0 · Grant/award (A): 9,756 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | F-star Therapeutics, Inc. (FSTX) | Code (U): 30,898 @ $7.12 · Disposition to issuer (D): 25,539 @ $7.12 · Disposition to issuer (D): 28,426 (derivative) · Disposition to issuer (D): 25,894 (derivative) · Disposition to issuer (D): 59,823 (derivative) · Disposition to issuer (D): 24,902 (derivative) | EDGAR |
| 2022-04-04 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 24,902 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 59,823 (derivative) @ $0 | EDGAR |
| 2021-08-24 | 4/A | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 26,437 @ $0 | EDGAR |
| 2021-03-11 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 25,894 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2020-11-24 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 28,426 (derivative) @ $0 · Grant/award (A): 26,437 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1089409 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs